Pfizer Grant Request Process for Healthcare and Clinical Science | Pfizer Professionals

Pfizer is continuously striving to improve its process with the goal of ensuring regulatory compliance while providing independent grants to support initiatives that accelerate the translation of clinical science into quality patient care.

 

In certain clinical areas, a General Request for Proposal (RFP)* will be posted. The Request for Proposal (RFP) provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

Currently open General RFPs:

Geographic Scope Issue Date RFP Title

Submission Deadline

United States December 12, 2019 Advances in Atopic Dermatitis for Community Pharmacists and Managed Care Health Care Professionals January 22, 2020
Worldwide December 11, 2019 Accredited CME Activity at ISTH 2020 January 23, 2020
Japan December 13, 2019 Cancer Pain Management February 7, 2020

To view previously posted RFPs that are now closed (i.e., applications no longer accepted) please click here.

*formerly called CGAs (Call for Grant Applications) 

Clinical Areas Reviewed through Joint Alliances/Partnerships

Please note, in order to apply to any of the Joint Alliance/Partnership programs listed below your organization must also meet Pfizer’s eligibility requirements. Click here to view further details about eligibility.

  • Chronic Pain Associated with Osteoarthritis and Chronic Low Back Pain

    Pfizer and Lilly are working together on grants in support of medical education in chronic pain associated with osteoarthritis and chronic low back pain. We are committed to supporting innovative, independent medical education for healthcare professionals.

    All grant applications should be submitted to Pfizer only, to avoid application duplication. To apply now, go to our grant management system.

  • Diabetes Treatment 

    Pfizer and Merck are working together on grants in support of diabetes treatment-related education. The goal of this education is to increase the understanding of SGLT2 inhibition in the management of diabetes.

    All grant applications should be submitted to Merck only. Please refer to the Merck website for information.

  • Nonsteroidal Anti-Androgen Treatment of Prostate & Breast Cancer

    Pfizer and Astellas are working together on grants in support of prostate cancer-related education. The goal of this education is to increase the ability of healthcare professionals to consistently provide their patients with optimal guidelines-based care.

    Pfizer and Astellas are also invested in advancing the understanding of nonsteroidal anti-androgens in the treatment of breast cancer.

    All grant applications should be submitted to Astellas only. Please refer to the Astellas website for information.

  • Thrombosis Prevention / Anti-coagulation

    Pfizer and Bristol Myers Squibb (BMS) are working together on grants in support of thrombosis / anticoagulation-related education. The goal of this education is to decrease the unmet medical needs in the prevention and treatment of venous and arterial thrombosis.

    All grant applications should be submitted to Bristol Myers Squibb only. Please refer to the Bristol Myers Squibb website for information.

 

Organizations Eligible to Receive Grants and Process Overview

Pfizer is committed to supporting healthcare quality improvement initiatives, continuing professional development and other independent education activities, including CME/CE, that are most likely to improve patient health, and believe that the likelihood of improving patient health increases when education is integrated with quality. We believe commercial support should be aligned with the literature on effective continuing education for health professionals, and the highest level of standards endorsed by the medical community such as those found in the 2006 ACCME criteria.

Types of organizations eligible to apply for grants include hospitals, academic medical centers, schools of nursing or pharmacy, professional societies and associations, and other entities with a mission related to healthcare professional education and/or healthcare improvement.View further details about eligibility.

View the full description of the grant application process.

 

Policies

Throughout the year Independent Grants for Learning & Change (IGLC) may send out communications directly to registered users of the Pfizer Grant Management System (GMS) with regard to important and time-sensitive topics (e.g., change in policy, changes in process or procedures, system enhancements). Such communications are posted below for your reference in descending chronological order. In addition to announcements prepared by IGLC, posted below you will find other relevant information we wish to share with our stakeholder community.

 




Date Posted Description Link
01/31/16 IGLC Sunshine FAQ - updated Jan 2016
02/28/15 IGLC Sunshine FAQ - updated Feb 2015
10/02/13 Press Release: International Atherosclerosis Society And Pfizer Independent Grants For Learning & Change Collaborate On New Grant Opportunity
08/30/13 Sunshine FAQ following IGLC webinar
08/01/13 Sunshine Act: Final Regulations and Implications for our Independent Grants Program
04/08/13 Pfizer IGLC announces new name
01/02/13 NEW online Grant Management System
09/13/12 Women's Health Platform
02/07/12 FAQ about new model
01/03/12 Pfizer MEG announces new model
12/27/11 Seeking nominations for External Review Panel Members
03/25/11 Pfizer Medical Education Group — King integration
11/04/09 Pfizer's support of ACCME Transparency Statement
10/20/09 Pfizer Medical Education Group – integration
12/03/08 Change in Pfizer's CME Grant Policy pursuant to state Attorneys General settlement-CME faculty with promotional speaking involvement
9/15/08 Pfizer's response to ACCME Call for Comments
7/18/08 Statement on Pfizer's recent policy change re CME support
7/18/08 FAQs re Pfizer's recent policy change re CME support
7/02/08 Pfizer announces policy change re CME support

 

File Description

Approved Full Proposal Final Report Overview

Upon completion of a project funded through a Request for Proposal (RFP), grant recipients will be asked to complete a "Full Proposal Final Report". This is a copy of the final report questions that will be asked.

Approved Full Proposal Interim Report Overview

 

Throughout the lifecycle of a project funded through a Request for Proposal (RFP), grant recipients will be asked to complete a "Full Proposal Interim Report". This is a copy of the interim report questions that will be asked.

Request for Scope Change

If a request for a timeline extension/scope change is received by Pfizer, a report will be assigned to the Grant Requestor in the Grant Management System. This is a copy of the questions that will be asked. 

Project Classification Decision Matrix

There are multiple project types that are eligible for funding through an IGLC RFP. When submitting for funding, organizations will be asked to indicate which of the following best represents their project.

  • Dissemination and Implementation (D&I) Research
  • Quality Improvement  Education
  • Educational research

This file provides more information on these classifications.

RFP - Terms & Conditions

Every Request for Proposal (RFP) released by Pfizer Independent Grants for Learning & Change (IGLC), as well as a RFP released jointly with a Partner(s), is governed by specific terms and conditions. This is a copy of the terms and conditions.

CGA - Terms & Conditions

Every Call for Grant Application (CGA) released by Pfizer Independent Grants for Learning & Change (IGLC) isgoverned by specific terms and conditions. This is a copy of the terms and conditions.